Roche withdraws refiling of Premerger Notification, Report Form under the HSR Act Farhat Nasim28 April 2019 9:45 AM ISTRoche has elected to withdraw and refile the Premerger Notification and Report Form under the HSR Act.New Delhi: Roche and Spark Therapeutics, Inc....
Novartis division Alcon spinoff ousts Baer from Swiss benchmark SMI Medical Dialogues Bureau5 April 2019 9:00 AM ISTNovartis has estimated Alcon's value at around 25 billion Swiss francs ($25 billion), while some analysts predict an initial market capitalisation of...
Pfizer to raise US drug prices in January after previously backing down under Trump pressure Medical Dialogues Bureau19 Nov 2018 1:14 PM ISTNEW YORK: Pfizer Inc has recently announced that it plans to hike U.S. prices on 41 of its medicines in January, after walking back its previous...
Illumina wins 26.7 million dollars in patent fight with Roche unit Ariosa Medical Dialogues Bureau28 Jan 2018 9:30 AM ISTGene testing company Illumina won a $26.7 million jury verdict in a U.S. lawsuit accusing rival Ariosa Diagnostics, a subsidiary of Roche Holdings AG,...
Roche plea in HC on cancer drug not maintainable: Biocon, Mylan Ruby Khatun Khatun12 Jan 2018 10:27 AM ISTNew Delhi: Generic drug makers Biocon and Mylan told the Delhi High Court that Swiss pharma major Roche's civil suit, challenging DCGI approvals...
Roche lymphoma drug drives high remission rate, longer survival: study Ruby Khatun Khatun12 Dec 2017 10:00 AM ISTAn experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced,...
Gilead Sciences new drug keeps 56 percent of lymphoma trial patients alive Ruby Khatun Khatun11 Dec 2017 10:30 AM ISTMore than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a...
More than 2,000 drugs now in cancer immunotherapy race Ruby Khatun Khatun9 Dec 2017 10:00 AM ISTLONDON: The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with...
Roche drug cocktail doubles chance of holding lung cancer at bay Ruby Khatun Khatun9 Dec 2017 9:45 AM ISTZURICH: Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease...
Roche's Foundation Medicine wins FDA approval for new cancer test Ruby Khatun Khatun6 Dec 2017 9:30 AM ISTZURICH: Roche on Monday said its Foundation Medicine unit won U.S. Food and Drug Administration (FDA) approval for a test to help doctors understand...
Merck KGaA, Pfizer's immunotherapy fails in gastric cancer trial Ruby Khatun Khatun1 Dec 2017 9:30 AM ISTFRANKFURT: Germany's Merck KGaA has suffered a setback in the development of key cancer immunotherapy Bavencio, it has failed in a trial to prolong...
Roche Diabetes Care eyes 51 percent market share in India by 2019 Ruby Khatun Khatun27 Nov 2017 10:18 AM ISTNew Delhi: Roche Diabetes Care India is aiming to have up to 51 percent market share in blood glucose monitoring segment in the country by the end of...
